Litcius/Paper detail

Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of Cardiology

Pasquale Perrone Filardi, Stefania Paolillo, Piergiuseppe Agostoni, Christian Basile, Cristina Basso, Francesco Barillà, Michele Correale, Antonio Curcio, Massimo Mancone, Marco Merlo, Marco Metra, Saverio Muscoli, Savina Nodari, Alberto Palazzuoli, Roberto Pedrinelli, Roberto Pontremoli, Michele Senni, Massimo Volpe, Ciro Indolfi, Gianfranco Sinagra

2022European Journal of Internal Medicine22 citationsDOIOpen Access PDF

Topics & Concepts

SacubitrilMedicineValsartanEnalaprilHeart failureInternal medicineSacubitril, ValsartanCardiologyEjection fractionAldosteroneNeprilysinClinical trialAliskirenSpironolactoneRenin–angiotensin systemAngiotensin-converting enzymeBlood pressureEnzymeBiochemistryChemistryHeart Failure Treatment and ManagementCardiac pacing and defibrillation studiesCardiovascular Function and Risk Factors
Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of Cardiology | Litcius